Dr. Rosemara Hughart, MD

Dr. Hughart practices at Sagis Diagnostics - Houston (Directors Row) in Houston, Texas.

Dr. Hughart's NPI, 1538468772, was assigned on March 25, 2011. Dr. Hughart holds Massachusetts license 265908.

Dr. Hughart's primary practice is Sagis Diagnostics - Houston (Directors Row), at 4131 Directors Row, Houston, TX 77092. The practice phone is (877) 697-2447.

Dr. Hughart's primary practice is Sagis Diagnostics - Houston (Directors Row) in Houston, Texas. Dmand AI also links Dr. Hughart to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hughart practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Hughart's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Hughart is licensed in Massachusetts.

CMS data shows 7,634 Medicare services from Dr. Hughart across 16 procedure codes in 2024, for 999 Medicare patients. Medicare paid $321,311 for them. Every service was in an office.

CMS counts 999 Medicare patients who saw Dr. Hughart in 2024. The largest group is 75 to 84, with 445 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hughart's median patient age at 74, with 59% women.

In 2024, Dr. Hughart wrote 915 Medicare Part D claims for 386 patients. 87% of them were for generic drugs. CMS names the drug for 785 of them, across 18 drugs with 11 or more claims each, at $330,111 in total drug cost. In 2023, CMS named 645 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Hughart for performance year 2024, reported individually. Dr. Hughart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,576 procedures of removal of skin lesions by Dr. Hughart, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Hughart in 2016. 2016 was the busiest year, with 2. Dr. Hughart has published most often in JAMA Dermatol. Dr. Hughart's most frequent co-authors are Kapila V. Paghdal, MD, Maria Magdalene Tsoukas, MD, PhD and Amanda Hope Champlain, MD.

CMS Open Payments shows 12 general payments to Dr. Hughart from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 87% of the total. Celgene Corporation paid the most, $281.